Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human FCRLB/FCRY Antibody, R&D Systems™

Sheep Polyclonal Antibody
Supplier: R&D Systems AF4705SP
This item is not returnable.
View return policy
Description
FCRLB/FCRY Polyclonal specifically detects FCRLB/FCRY in Human samples. It is validated for Western Blot.Specifications
| FCRLB/FCRY | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| Fc receptor homolog expressed in B cells protein 2, Fc receptor like 2, Fc receptor-like and mucin-like 2, Fc receptor-like and mucin-like protein 2, Fc receptor-like B, Fc receptor-like protein 2, Fc receptor-related protein Y, FcRL2, FCRL2FCRLM2, FCRLM2, FCRLY, FCRY, FLJ31052, FREB2, FREB-2, FREB-2FcRY, RP11-474I16.6 | |
| Sheep | |
| Affinity Purified | |
| RUO | |
| 127943 | |
| Sterile PBS to a final concentration of 0.2 mg/mL. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot | |
| LYOPH | |
| Western Blot 1 ug/mL | |
| Q6BAA4 | |
| FCRLB | |
| Mouse myeloma cell line NS0-derived recombinant human FCRLB/FCRY Ala18-Ser426 Accession # Q6BAA4 | |
| 25 μg | |
| Primary | |
| Detects human FCRLB/FCRY in direct ELISAs and Western blots. In direct ELISAs, approximately 30% cross-reactivity with recombinant mouse (rm) FCRLB/FCRY is observed, and less than 1% cross-reactivity with recombinant human FCRN and rmFCRN is observed. | |
| Human | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction